If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Shareholding

26 Jan 2017 10:10

RNS Number : 2106V
Scapa Group PLC
26 January 2017
 

26 January 2017

SCAPA GROUP PLC

('the Company')

Director/PDMR Notification

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Scapa Group plc (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets, was notified on 25 January 2017 that James Archibald Simpson Wallace, Group Chairman of the Company, sold 150,000 ordinary shares of 5 pence each in the share capital of the Company ('Ordinary Shares') at a price of 320 pence per Ordinary Share and 250,000 ordinary shares of 5 pence each in the share capital of the Company ('Ordinary Shares') at a price of 321 pence per Ordinary Share on 25 January 2017, as detailed below.

On 15 December 2016, Mr Wallace announced his retirement as Chairman of the Board of Scapa Group plc with effect from 31 March 2017, at which point Mr Larry Pentz will assume Chairmanship.

Following the sale Mr. Wallace holds 70,000 Shares in the Company.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Archibald Simpson Wallace

 

2

Reason for the notification

a)

Position / status

Group Chairman

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of financial instrument,

type of instrument

 

Ordinary shares of 5p each

Identification Code

GB0007281198

b)

Nature of the transaction

Sale of shares

 

c)

Price(s) and volume(s)

 

Sale of 150,000 shares at 320p per share

Sale of 250,000 shares at 321p per share

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

25 January 2017

f)

Place of the transaction

London

 

For further information please contact:-

 

Graham Hardcastle Group Finance Director/Company Secretary

Scapa Group plc

Tel: 0161 301 7400

 

Richard Thomas Numis Securities Limited

Nominated Adviser and Joint Broker

Tel: 0207 260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUNRRRBKAAUAR
Date   Source Headline
19th May 20201:35 pmRNSStandard form for notification of major holdings
14th May 202012:06 pmRNSResults of Placing
14th May 20207:00 amRNSTrading Update, Financing and Proposed Placing
7th May 20207:00 amRNSUpdate on Notice of Full Year Results
4th May 20207:00 amRNSDirectorate Changes
30th Apr 202010:20 amRNSTotal Voting Rights
27th Apr 20203:03 pmRNSHolding(s) in Company
16th Apr 20209:33 amRNSAdditional Listing of Shares
31st Mar 202010:00 amRNSTotal Voting Rights
27th Mar 20207:00 amRNSCOVID-19 UPDATE
20th Mar 202012:07 pmRNSSecond Price Monitoring Extn
20th Mar 202012:02 pmRNSPrice Monitoring Extension
17th Mar 202010:00 amRNSBlock Listing Application
3rd Mar 202012:07 pmRNSSecond Price Monitoring Extn
3rd Mar 202012:02 pmRNSPrice Monitoring Extension
2nd Mar 20209:41 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSScapa Group Directorate Change
27th Feb 202011:44 amRNSHolding(s) in Company
14th Feb 20209:00 amRNSHolding(s) in Company
12th Feb 202010:00 amRNSHolding(s) in Company
12th Feb 20207:00 amRNSTrading Update
31st Jan 202010:15 amRNSTotal Voting Rights
24th Jan 202010:45 amRNSBlock listing six monthly return
20th Jan 20202:38 pmRNSDirectorate Appointment
2nd Jan 20202:06 pmRNSTotal Voting Rights
29th Nov 201911:08 amRNSTotal Voting Rights
28th Nov 20192:41 pmRNSStandard form for notification of major holdings
22nd Nov 20191:17 pmRNSCorrection - Holding(s) in Company
21st Nov 201910:14 amRNSHolding(s) in Company
19th Nov 20197:00 amRNSScapa Group: Interim Results
12th Nov 20194:16 pmRNSStandard form for notification of major holdings
31st Oct 20199:58 amRNSTotal Voting Rights
25th Oct 20197:00 amRNSNotice of Results
9th Oct 20197:00 amRNSPeriod end update
30th Sep 20199:20 amRNSTotal Voting Rights
13th Sep 201911:19 amRNSDirector/PDMR Shareholding
30th Aug 20199:22 amRNSTotal Voting Rights
7th Aug 20194:29 pmRNSAdditional Listing
31st Jul 20193:29 pmRNSTotal Voting Rights
25th Jul 201910:30 amRNSBlock listing Interim Review
23rd Jul 20194:39 pmRNSResult of AGM
23rd Jul 20197:00 amRNSAGM Statement
11th Jul 20197:00 amRNSScapa commences legal action against ConvaTec
9th Jul 201910:38 amRNSAdditional Listing
2nd Jul 20191:37 pmRNSTotal Voting Rights
28th Jun 20193:36 pmRNSDirectorate Change
21st Jun 20192:05 pmRNSDirector/PDMR Shareholding
19th Jun 201912:49 pmRNSHolding(s) in Company
18th Jun 20198:46 amRNSDirector/PDMR Shareholding
14th Jun 20199:36 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.